These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3781425)

  • 1. Metabolizing systems in short-term in vitro tests for carcinogenicity.
    Platt KL; Utesch D; Gemperlein-Mertes I; Glatt HR; Oesch F
    Food Chem Toxicol; 1986; 24(6-7):721-9. PubMed ID: 3781425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies.
    Glatt H; Gemperlein I; Turchi G; Heinritz H; Doehmer J; Oesch F
    Mol Toxicol; 1987-1988 Fall; 1(4):313-34. PubMed ID: 3151500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of bioactivation of chemical carcinogens.
    Glatt HR
    Biochem Soc Trans; 2000 Feb; 28(2):1-6. PubMed ID: 10816089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic perspectives on in vitro toxicity tests.
    Oesch F; Glatt H; Utesch D
    Xenobiotica; 1988 Jan; 18 Suppl 1():35-44. PubMed ID: 3125692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays.
    Rueff J; Chiapella C; Chipman JK; Darroudi F; Silva ID; Duverger-van Bogaert M; Fonti E; Glatt HR; Isern P; Laires A; Léonard A; Llagostera M; Mossesso P; Natarajan AT; Palitti F; Rodrigues AS; Schinoppi A; Turchi G; Werle-Schneider G
    Mutat Res; 1996 Jun; 353(1-2):151-76. PubMed ID: 8692190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.
    Madle S; Obe G
    Hum Genet; 1980; 56(1):7-20. PubMed ID: 7009387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations.
    Kranendonk M; Laires A; Rueff J; Estabrook WR; Vermeulen NP
    Crit Rev Toxicol; 2000 May; 30(3):287-306. PubMed ID: 10852498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of carcinogens, possibilities for modulation.
    Oesch F
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():15-33. PubMed ID: 6385619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of xenobiotics in Drosophila melanogaster and its relevance for mutagenicity testing.
    Baars AJ
    Drug Metab Rev; 1980; 11(2):191-221. PubMed ID: 6783378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term modulation of the enzymatic control of mutagenic and carcinogenic metabolites.
    Oesch F
    Prog Clin Biol Res; 1986; 209A():495-506. PubMed ID: 3749063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of parenchymal versus non-parenchymal cells in the control of biologically reactive intermediates.
    Oesch F; Lafranconi M; Glatt HR
    Adv Exp Med Biol; 1986; 197():53-61. PubMed ID: 3766279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung and liver cell-mediated mutagenesis systems: specificities in the activation of chemical carcinogens.
    Langenbach R; Nesnow S; Tompa A; Gingell R; Kuszynski C
    Carcinogenesis; 1981; 2(9):851-8. PubMed ID: 6271413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of aromatic amines to mutagens by bovine bladder and liver cells.
    Oglesby L; Hix-Baker C; MacNair P; Sieg M; Snow L; Langenbach R
    Environ Health Perspect; 1983 Mar; 49():147-54. PubMed ID: 6339223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte-mediated mutagenicity of mononitrobenzo[a]pyrenes in Salmonella typhimurium strains.
    Hass BS; Heflich RH; Chou MW; White GL; Fu PP; Casciano DA
    Mutat Res; 1986; 171(2-3):123-9. PubMed ID: 3528834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.